Olema Pharmaceuticals (OLMA)
(Delayed Data from NSDQ)
$11.85 USD
-0.89 (-6.99%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $11.86 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.57 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | 0.00% |
ABR | 1.00 |
Earnings ESP
|
0.79% |
---|---|
Current Year | -1.50 |
Next Year | -2.54 |
EPS (TTM) | -2.07 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.57 | 0.17 | -1.50 | -2.54 |
# of Estimates | 7 | 6 | 7 | 6 |
Most Recent Consensus | -0.57 | -0.60 | -2.27 | -2.74 |
High Estimate | -0.50 | 4.08 | 3.41 | -2.20 |
Low Estimate | -0.61 | -0.68 | -2.40 | -2.80 |
Year ago EPS | -0.48 | -0.49 | -2.14 | -1.50 |
Year over Year Growth Est. | -18.75% | 134.69% | 29.91% | -69.19% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 3 | 2 | 3 | 2 |
Up Last 30 Days | 3 | 2 | 3 | 2 |
Up Last 60 Days | 3 | 2 | 3 | 2 |
Down Last 7 Days | 2 | 3 | 3 | 2 |
Down Last 30 Days | 2 | 3 | 3 | 2 |
Down Last 60 Days | 2 | 3 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.57 | 0.17 | -1.50 | -2.54 |
7 Days Ago | -0.56 | 0.19 | -1.48 | -2.44 |
30 Days Ago | -0.56 | 0.19 | -1.48 | -2.44 |
60 Days Ago | -0.56 | 0.19 | -1.48 | -2.44 |
90 Days Ago | -0.61 | 0.13 | -1.60 | -2.65 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.57 | 0.34 | -1.35 | -2.56 |
Zacks Consensus Estimate | -0.57 | 0.17 | -1.50 | -2.54 |
Earnings ESP | 0.79% | 100.80% | 9.94% | -1.14% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | -0.56 | -0.49 | -0.48 | NA |
Estimate | -0.54 | -0.53 | -0.49 | -0.51 | NA |
Difference | 0.00 | -0.03 | 0.00 | 0.03 | 0.00 |
Surprise | 0.00% | -5.66% | 0.00% | 5.88% | 0.06% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more